Concurrent Gainers: ICICI Bank among 9 stocks that gained for 5 days in a row
In the five trading sessions leading up to September 20, the Sensex rose approximately 2%, closing at 84,544, with gains noted in four sessions. In this weekly rally, ETMarkets identified that nine stocks from the Nifty500 pack have showed consistent price increases during this timeframe. (Data Source: ACE Equity)
SBI among top 10 stock picks from Axis Securities with upside potential of up to 42%
The long-awaited 50 bps rate cut by the Federal Reserve has finally happened, with the Fed hinting at further reductions in 2024, 2025, and 2026. This news has sparked a positive reaction across the markets.Following this, analysts expect increased FPI inflows, leading to a recent rise in largecap investments. This trend may strengthen, with largecaps […]
These 5 BSE smallcap stocks see price and volume jump in last 3 days
Recent analysis by ETMarkets reveals that five BSE smallcap stocks experienced consistent growth in price, trading volume, and delivery volume over the past three sessions. This surge suggests heightened investor interest in these specific smallcap companies.
Life Insurance sector has strong growth potential amid regulatory changes; HDFC Life, SBI Life top picks
Private insurers in India saw a significant increase in their weighted received premium (WRP) during August 2024, growing 15% year-on-year. This was notably higher than the overall industry growth of 10%. Combined with ongoing investments in distribution and new product development, this indicates a positive outlook for the private insurance sector in India.
Wall St Week Ahead: Investor focus turns to data, election, earnings after Fed cut
U.S. stocks face a challenging period with economic data, political uncertainty, and corporate earnings tests ahead. The S&P 500 recently hit an all-time high following a Federal Reserve rate cut but remains vulnerable to market swings, especially with the upcoming election and key economic reports on the horizon.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
India’s Solar Energy Corporation mulls IPO, to invest $2.2 billion in renewables by 2030
State-owned Solar Energy Corporation of India (SECI) on Friday pledged to invest 180 billion rupees ($2.16 bln) in equity for renewable capacity expansion by 2030, and announced plans to go public in the next one to two years.
Adani Energy Solutions shares could deliver multibagger returns from current levels
Cantor initiates coverage on the company with a bullish “Overweight” rating and a price target of Rs 2,251, suggesting a potential 129% upside by FY26. They project a 20% CAGR revenue growth and a 28.8% CAGR adjusted EBITDA growth for the company from FY24 to FY27E.
Leela hotels owner Schloss Bangalore files for $599 million India IPO
The company would issue fresh shares worth 30 billion rupees, while existing shareholder Project Ballet Bangalore Holdings (DIFC) will sell shares worth 20 billion rupees.
Sebi relaxes financial disincentives norms for technical glitches, restricts it to Market Infrastructure Institutions
Securities and Exchange Board of India (Sebi) on Friday relaxed rules governing financial disincentives imposed by the regulator on Market Infrastructure Institutions (MIIs) and individuals for omissions and commissions leading to technical glitches.